# Cre-Lox recombination
**Cre-Lox recombination** is a site-specific genetic recombination technique in which the [Cre recombinase](https://www.edgepedia.org/cre-recombinase) enzyme, derived from bacteriophage P1, rearranges DNA at pairs of 34-base-pair sequences called loxP sites, allowing deletions, insertions, inversions, and translocations to be made at chosen locations in a genome. It is an integral experimental tool for mammalian genetics and cell biology, providing spatial and temporal control of gene expression, particularly in the mouse.[1](https://pubmed.ncbi.nlm.nih.gov/28252198/)
| Key fact | Detail |
|---|---|
| Enzyme | Cre recombinase, a 343-amino-acid, 38 kDa protein encoded by the *cre* gene of coliphage P1[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC5910175/) • [6](https://academic.oup.com/nar/article/17/1/147/1191696) |
| Target site | loxP ("locus of crossover (x) in P1"), 34 bp: two 13 bp palindromic Cre-binding sites flanking an 8 bp core[8](https://journals.physiology.org/doi/10.1152/physiolgenomics.00074.2002) • [3](https://pmc.ncbi.nlm.nih.gov/articles/PMC4929723/) |
| Outcome by orientation | loxP sites in the same direction excise the intervening sequence; sites in opposite directions invert it[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC4929723/) |
| First mammalian use | Cre-stimulated recombination demonstrated at loxP sites on a mouse chromosome in 1989 (Sauer and Henderson)[6](https://academic.oup.com/nar/article/17/1/147/1191696) |
| In vivo milestone | Implemented in mice in vivo in 1994, after first use in T-cells and then neuronal tissue[4](https://www.nature.com/articles/s41540-025-00542-w) • [2](https://pmc.ncbi.nlm.nih.gov/articles/PMC5910175/) |
| Practical advantages | No cofactors required; recombination loses or gains no nucleotides; the 34 bp site is small enough not to perturb neighboring genes; Cre acts on supercoiled, relaxed, or linear DNA and over megabase distances[8](https://journals.physiology.org/doi/10.1152/physiolgenomics.00074.2002) |
| Main limitations | Unpredictable recombination efficiency and mosaicism; germline recombination; sensitivity to chromatin state and inter-loxP distance[11](https://genomebiology.biomedcentral.com/counter/pdf/10.1186/s13059-025-03560-3) • [2](https://pmc.ncbi.nlm.nih.gov/articles/PMC5910175/) |
## Mechanism
Cre recognizes pairs of loxP sites and promotes strand exchange within the 34 bp site. Each loxP site consists of left and right 13 bp inverted repeats surrounding an 8 bp spacer, and the spacer sequence gives the site its directionality; misaligned pairing of sites produces mismatched spacers in the recombination intermediates and products.[10](https://pmc.ncbi.nlm.nih.gov/articles/PMC2904746/) The reaction proceeds through a Holliday-junction intermediate (A four-stranded DNA cross structure formed transiently during recombination) in which covalently attached Cre monomers hold the aligned sites together.[10](https://pmc.ncbi.nlm.nih.gov/articles/PMC2904746/)
Orientation determines the outcome. When two loxP sites are oriented in the same direction, productive recombination excises the DNA between them as a circular fragment; when they are oriented in opposite directions, the intervening sequence is inverted to its reverse complement.[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC4929723/) Because the excised fragment is lost, excision is effectively irreversible in a cell, whereas inversion remains reversible.
The distance between sites matters. [In vitro](https://www.edgepedia.org/in-vitro) trials show a sharp decrease in recombination efficiency when the sequence separating two loxP sites is shorter than 94 bp; recombination remains detectable at low levels at 82 bp but not at 80 bp, where DNA stiffness appears to prevent the loop formation needed for the two sites to interact.[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC4929723/) At the other extreme, Cre functions over large genomic distances, including megabase separations.[8](https://journals.physiology.org/doi/10.1152/physiolgenomics.00074.2002)
## History
Sternberg and Hamilton showed in 1981 that bacteriophage P1 contains a recombination hot spot resolved by Cre protein acting at loxP sites, and that *loxP* and the *cre* gene are separate but adjacent segments of the phage DNA.[12](https://scholarworks.indianapolis.iu.edu//bitstreams/d2e6f99e-52f7-442d-a3c5-93871254beff/download) In 1989, Brian Sauer and Nancy Henderson showed that Cre could act on loxP sites resident on a mammalian chromosome: in a mouse cell line carrying two directly repeated loxP sites flanking a 2.5 kb yeast DNA fragment inserted to disrupt a selectable marker gene, expression of *cre* excised the fragment and restored marker expression, events that were quite rare without Cre.[6](https://academic.oup.com/nar/article/17/1/147/1191696)
With the development of transgenic mice, in which novel DNA sequences could be stably and heritably introduced into the genome, the Cre-lox system was first implemented in T-cells and then in neuronal tissue.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC5910175/) The system was implemented in mice in vivo in 1994, and it has since become one of the most fundamental and commonly used site-specific recombinase systems in lineage tracing and conditional genetics.[4](https://www.nature.com/articles/s41540-025-00542-w)
## Conditional gene manipulation in mice
The most common use is cell-specific gene inactivation or activation. A gene of interest is flanked by loxP sites (a "floxed" allele), typically around essential exons, and a mouse expressing Cre under a cell-type-specific promoter is crossed in; where Cre is active, the floxed sequence is excised.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC5910175/) • [9](https://pmc.ncbi.nlm.nih.gov/articles/PMC7771386/) In lineage tracing, Cre often excises a STOP codon between two loxP sites to activate a fluorescent reporter, with specificity determined by the promoter driving Cre.[4](https://www.nature.com/articles/s41540-025-00542-w)
**Temporal control** is added with inducible Cre variants such as CreERT2, activated by tamoxifen; titrating the tamoxifen dose limits recombination to a sparse subset of cells, which permits clonal analysis at the single-cell level.[4](https://www.nature.com/articles/s41540-025-00542-w)
**Efficiency is not uniform.** A systematic study in mice examined Cre-driver strain, inter-loxP distance, breeder age at mating, zygosity of the floxed allele, wild-type versus mutant loxP sites, and genomic locus, all of which affect recombination efficiency and mosaicism, meaning incomplete recombination across the target tissue.[11](https://genomebiology.biomedcentral.com/counter/pdf/10.1186/s13059-025-03560-3) [DNA methylation](https://www.edgepedia.org/dna-methylation), transcriptional activity, and chromatin structure at the locus also influence efficiency.[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC4142476/) The same Cre line may recombine one locus at only 10% efficiency while targeting another gene across many cell types or the entire body.[9](https://pmc.ncbi.nlm.nih.gov/articles/PMC7771386/)
**Unintended recombination** is a recognized pitfall. Germline recombination and transient Cre expression during development can produce fully recombined alleles inherited by all offspring, and conventional genotyping may fail to detect these events; transient Cre expression requires very little enzyme to act on loxP sites.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC5910175/) Random integration site and variable copy number in transgenic Cre lines also make Cre expression levels variable between lines.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC5910175/)
## Variant sites and dual systems
Mutant loxP sites enable more complex designs. Heterotypic site pairs recombine only within matching types: lox2272 recombines proficiently with another lox2272 but not with wild-type loxP, while lox511 recombines with wild-type loxP at only 1% to 5% efficiency, making it less effective for strategies that require strict site discrimination.[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC4142476/) These incompatible site variants are the basis of recombinase-mediated cassette exchange designs.[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC4142476/)
The Cre-loxP system also combines with analogous recombinase systems. Dre-rox, in which the Dre recombinase acts on rox sites, is a common heterospecific partner, and dual systems allow expression logic such as recombination by either enzyme, by both, or by one in the absence of the other.[4](https://www.nature.com/articles/s41540-025-00542-w) The Flp-FRT system is an analogous alternative; a high-efficiency FLPe deleter strain (FLPeR) targeted to the ROSA26 locus demonstrates Flpe as a workable substitute for Cre-loxP in mice.[8](https://journals.physiology.org/doi/10.1152/physiolgenomics.00074.2002)
## Applications
**Lineage tracing.** Cre-loxP is described as the gold standard in lineage-tracing studies, valued for widespread availability, versatility, and ease of use.[4](https://www.nature.com/articles/s41540-025-00542-w) Multicolor reporter cassettes extend it to clonal analysis: Brainbow expresses up to four different fluorescent proteins through stochastic Cre-loxP-mediated excision and inversion among multiple loxP pairs, and the R26R-Confetti reporter is a widely used adaptation applied in hematopoietic, epithelial, kidney, and skeletal tissues.[4](https://www.nature.com/articles/s41540-025-00542-w) Barcoding designs exploit the minimal interaction distance between lox sites to freeze stable random barcodes; four concatenated alternating lox cassettes with poorly interacting site variants yield a code diversity greater than 1012.[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC4929723/)
**Plant biotechnology.** In plants, Cre-lox is used primarily for controlled excision of DNA fragments, especially selectable marker genes, from nuclear and chloroplast genomes, and for targeted insertion of DNA at specific nuclear loci.[5](https://www.sciencedirect.com/science/article/pii/S0167779903002609)
**Neuroscience and disease models.** Cre-recombinase systems provide cell-specific gene deletion for neuron-specific knockout models and are widely used to build genetic models of disease.[13](https://pubmed.ncbi.nlm.nih.gov/35900402/) • [14](https://core.ac.uk/download/212695925.pdf)
## References
1. [Cre-loxP-Mediated Recombination: General Principles and Experimental Considerations, Current Protocols (2017)](https://pubmed.ncbi.nlm.nih.gov/28252198/)
2. [Detecting and Avoiding Problems When Using the Cre/lox System, Trends in Genetics (2018)](https://pmc.ncbi.nlm.nih.gov/articles/PMC5910175/)
3. [Site-specific recombinatorics: in situ cellular barcoding with the Cre Lox system (2016)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4929723/)
4. [Next generation lineage tracing and its applications to unravel development, npj Systems Biology and Applications (2025)](https://www.nature.com/articles/s41540-025-00542-w)
5. [Cre–lox recombination: Cre-ative tools for plant biotechnology, Trends in Plant Science (2003)](https://www.sciencedirect.com/science/article/pii/S0167779903002609)
6. [Sauer, B. & Henderson, N. Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome, Nucleic Acids Research 17, 147–161 (1989)](https://academic.oup.com/nar/article/17/1/147/1191696)
7. [Strategies to Achieve Conditional Gene Mutation in Mice (2011)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4142476/)
8. [Tools for targeted manipulation of the mouse genome, Physiological Genomics (2002)](https://journals.physiology.org/doi/10.1152/physiolgenomics.00074.2002)
9. [Conditional Gene-Targeting in Mice: Problems and Solutions (2016)](https://pmc.ncbi.nlm.nih.gov/articles/PMC7771386/)
10. [The Order of Strand Exchanges in Cre-LoxP Recombination and its Basis Suggested by the Crystal Structure of a Cre-LoxP Holliday Junction Complex (2000)](https://pmc.ncbi.nlm.nih.gov/articles/PMC2904746/)
11. [Systematic optimization and prediction of cre recombinase for precise genome editing in mice, Genome Biology (2025)](https://genomebiology.biomedcentral.com/counter/pdf/10.1186/s13059-025-03560-3)
12. [Thesis chapter on Cre recombination history, IUPUI ScholarWorks](https://scholarworks.indianapolis.iu.edu//bitstreams/d2e6f99e-52f7-442d-a3c5-93871254beff/download)
13. [Cre-recombinase systems for induction of neuron-specific knockout models: a guide for biomedical researchers (2022)](https://pubmed.ncbi.nlm.nih.gov/35900402/)
14. [Improving Outcomes (Cre-loxP mouse limitations)](https://core.ac.uk/download/212695925.pdf)
---
*Topic: Encyclopedia › Life and health › Applied biology and nonhuman health › Biotechnology and biological production › Bioprocess engineering and biomanufacturing › Recombinant proteins and enzyme technology › Restriction enzymes and cloning tools*
*Initially written Sep 17, 2026 · Reviewed: Sep 30, 2026; Oct 21, 2026 · Edited: Sep 30, 2026; Oct 21, 2026 · Last review: Oct 21, 2026*
*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*
License: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license